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Available online 29 June 2012Abstract Current strategies to monitor reprogramming into induced pluripotent stem cells (iPSCs) are limited in that
they rely on the recognition of advanced stage biomarkers or they involve the transduction of genetically-modified cells.
These limitations are particularly problematic in high-throughput screenings where cell availability, low cost and a rapid
experimental protocol are critical issues. Herein we report the application of a pluripotent stem cell fluorescent probe
(i.e. CDy1) as a reporter for the rapid screening of chemicals in reprogramming iPSCs. CDy1 stains early-stage iPSCs at
7 dpi as well as matured iPSCs; hence it can partially overcome the slow kinetics of the reprogramming process. As a proof
of concept, we employed a CDy1-based screening in 384 well-plates to examine the effect of newly synthesized
hydroxamic acid derivatives in reprogramming mouse fibroblasts transduced with Oct4, Sox2 and Klf-4 without c-Myc. One
compound (1–26) was identified as a reprogramming enhancer by 2.5-fold and we confirmed that 1–26 behaves as a
histone deacetylase (HDAC) inhibitor. The successful identification of novel small molecules enhancing the generation of
iPSCs by means of a rapid and simple protocol demonstrates the suitability of this CDy1-based screening platform for the
large scale and high-throughput evaluation of iPSC modulators.
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186 M. Vendrell et al.IntroductionInduced pluripotent stem cells (iPSCs) hold an enormous
potential for biomedical research (e.g. regenerative
medicine, drug discovery) (Rubin, 2008; Xu et al., 2008;
Deng, 2010) and current stem cell research pursues the
generation of iPSCs in an efficient and safe manner. Since
the original report of Takahashi and Yamanaka (2006),
different strategies with the aim at replacing the viral
transduction of exogenous transcription factors by small
molecules, proteins, mRNA or microRNA have been
described (Feng et al., 2009; Kim et al., 2009; Judson et
al., 2009; Warren et al., 2010). The evaluation of small
molecules has been probably the most studied approach,
partially due to the availability of large chemical
collections and the standardized procedures (e.g., high-
throughput screens) developed in some areas of medicinal
chemistry (Desbordes et al., 2008; Gonzalez et al., 2011;
Lyssiotis et al., 2011). Alkaline-phosphatase and
immunocytochemistry-based assays are commonly used
methods which rely on the recognition of iPSC markers at
an advanced stage of the reprogramming process (typically
12–14 days in mouse and longer in human) (Zhu et al.,
2010; Lin et al., 2009; Bone et al., 2009). An alternative is
the transduction or transfection of genetically-modified
cells that express reporters by the promoters of
iPSC-specific genes (e.g., Oct4, Nanog) and enable
tracking the reprogramming. Nanog-GFP (Green Fluores-
cent Protein) and Oct4-GFP have been used to monitor
iPSC reprogramming (Mikkelsen et al., 2008; Huangfu et
al., 2008) and Lyssiotis et al. (2009) developed a
Nanog-luciferase reporter that was successfully applied
to high-throughput chemical screening. The main
drawback of genetically-modified cells is their limited
availability, which may be critical for broad usage.
Besides, these genetic reporters usually ‘turn on’ at
relatively later stages of reprogramming. Our group
recently developed a fluorescent probe (CDy1) that
selectively stains pluripotent stem cells (Im et al., 2010;
Kang et al., 2011). CDy1 is a fluorescent small molecule
(absorption maximum: 535 nm; emission maximum:
570 nm) discovered from a high-throughput screening of
280 rosamine dyes in embryonic stem cells (ESC) and
mouse embryonic fibroblasts (MEFs). CDy1 showed
12.2-fold higher fluorescence intensity in mESC when
compared to MEF. Further studies proved that CDy1
could also stain mouse iPSCs (miPSCs) at early stages,
when the signal of an Oct4-GFP reporter was not
detectable. Time-course studies indicated that the early
fluorescent signal of CDy1 overlapped well with the signal
of Oct4-GFP at advanced stages of reprogramming (Im et
al., 2010). We envisioned that CDy1 could be used as a
fluorescent reporter to develop a high-throughput screen-
ing platform for the rapid evaluation of chemicals in
mouse iPSCs (miPSCs). In addition to overcoming the slow
kinetics of reprogramming, this platform would comprise
other advantages, such as the compatibility with both
genetically and non-genetically modified transduced cells,
the possibility to monitor the reprogramming process at
different time points and a low cost that may facilitate its
application to large collections of chemicals.Materials and methods
Cell culture and iPSC generation
MEFs for feeder were cultured in 10-cm dishes coated with
0.1% gelatin using high-glucose Dulbecco's Modified
Eagle's medium (DMEM) supplemented with 10% fetal calf
serum, 2 mM L-glutamine, 100 U/mL penicillin, 100 μg/
mL streptomycin, 0.1 mM non-essential amino acids and
0.1% β‐mercaptoethanol. For feeder cell preparation,
MEFs were treated with mitomycin C (10 μg/mL) for
2.25 h and washed with PBS (×1). For iPSC generation,
MEFs from E13.5 B6;CBATg(Pou5f1-EGFP)2Mnn/J mouse
(Jackson Laboratory) embryo at passage 3 were infected
with pMX-Oct4, Sox2, Klf4 retrovirus with or without cMyc
with 10 μg/mL polybrene (Sigma) in 10-cm dishes. After
24 h the media were changed to high-glucose DMEM with
20% knock-out serum replacement (KOSR, Invitrogen),
1 mM L-glutamine, 0.1 mM β-mercaptoethanol, 1% non-
essential amino acids and 100 U/mL leukemia inhibitory
factor (LIF, Chemicon). Transduced MEFs were seeded as
10,000–30,000 cells/well on feeder cells (30,000 cells/
well) in 12 well-plates for Oct4-GFP-based experiments or
as 4000 cells/well on feeder cells (1000 cells/well) in 384
well-plates for CDy1-based screens and incubated in a
humidified atmosphere at 37 °C with 5% CO2.Chemical treatment and CDy1-based screening
MEFs transduced with Oct4, Sox2 and Klf4 were seeded on
384 well-plates and treated at 2 dpi with chemicals to a
final concentration of 5 μM for hydroxamic acids
(containing 0.5% DMSO), 600 nM for 5′-azaC, 20 nM for
TSA and 2 μM for SB431542 in mESC media containing LIF
(100 U/mL). Four replicates were run for every treatment
and cells were incubated for 5 days in a humidified
atmosphere at 37 °C with 5% CO2. At 7 dpi, cells were
treated with CDy1 (final concentration: 100 nM) and
incubated for 1 h at 37 °C. Cells were washed with
mESC media and incubated at 37 °C for 2.5 h, then
incubated with mESC media containing Hoechst (1 μg/mL)
for nuclear counterstaining (15 min, 37 °C). Fluorescent
images of CDy1 and Hoechst-stained cells were acquired in
an ImageXpressMICRO system (TRITC filter for CDy1, DAPI filter
for Hoechst) at 10× magnification and analyzed using
MetaXpress 2.0 software (Molecular Devices, Inc. USA, www.
moleculardevices.com).Chemical and biological characterization of 1–26
The purity and identity of 1–26 were confirmed by HPLC–
MS and NMR (1H and 13C) (Figure S4). The biological
activity of 1–26 was evaluated using a HDAC inhibitor
drug screening kit (BioVision, catalog #K340-100)
according to the manufacturer's instructions and the
data analysis was performed using GraphPad Prism 5.0.
Cell viability assays were performed using a CellTiter 96®
AQueous non-radioactive cell proliferation assay kit
(Promega).
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differentiation assays
For immunocytochemistry assays, iPSCs (expanded at least
for six passages without chemical treatment) were fixed
with 4% paraformaldehyde for 10 min, washed with PBS and
blocked with 1% BSA for 30 min. Cells were then incubated
with a mouse monoclonal antibody against SSEA-1 (1:100,
Millipore) and a rabbit monoclonal antibody against Oct4
(1:100, Abcam) overnight at 4 °C, washed with PBS (×3) and
incubated for 3 h with Alexa594-conjugated goat anti-mouse
antibody (1:500, Invitrogen) and Cy5-conjugated goat
anti-rabbit antibody respectively. Fluorescence microscope
images were taken in a Nikon A1R confocal microscope using
FITC (Oct4-GFP), Texas Red (SSEA-1) and Cy5 (Oct-4) filters
and processed using the software NIS-Elements 3.10.
Total RNAs from chemical-treated iPSCs, MEFs and mESCs
were extracted with miRNeasy Mini Kit (QIAGEN). The
sequences of the primers for RT-PCR are included in the
Supporting Information. One-step quantitative RT-PCR was
performed on a StepOne™ Real-Time PCR System using a
Power SYBR® Green RNA-to-CT™ 1-Step Kit (Applied
Biosystems, USA, www.appliedbiosystems.com).
Differentiated cells from iPSC lines were obtained upon
10–12 days differentiation of embryoid bodies formed for
3 days in mESC growing media without LIF. Cells were fixed
as above mentioned, incubated with mouse monoclonal
antibodies against α-SMA (1:200, Abcam) or Nestin (1:200,
Millipore) and a goat polyclonal antibody against SOX-17Figure 1 A fluorescence-based high-throughput screening plat
reprogramming factors. Values as means±SD (n=4). Student's t-tes
pb0.001) compared to non-infected cells. B) Fluorescent microscop
well-plates (scale bar: 50 μm). Hoechst was used for nuclear counters
colony-like structures. C)Work flow: OSK-transducedMEFswere seeded
cells were treated with CDy1, washed and analyzed by high-throughp(1:200, R&D Systems) overnight at 4 °C, washed with PBS
(×3) and then incubated for 3 h, respectively, with Alexa
594-conjugated goat anti-mouse antibody (1:200, Invitrogen)
and Alexa 594-conjugated donkey anti-goat antibody (1:200,
Invitrogen) and Hoechst (0.1%, v/v) for nuclear counterstaining.
Fluorescent microscope images were taken in a Nikon Ti
epifluorescence microscope using the Texas Red filter
(α-SMA, Nestin, Sox17) and the DAPI filter for Hoechst
staining. Images were processed with the NIS-Elements
3.10 software.
In vivo teratoma assays
Cells suspended in PBS were injected subcutaneously into
the lower flanks of 8 weeks old SCID mice (3×106 cells per
site). The tumors grown under the skin were excised
6–8 weeks after the injection and fixed in 4% paraformal-
dehyde for paraffin embedding, sectioning and hematoxylin
and eosin staining. All animal experiment procedures were
performed in accordance with a protocol approved by the
Institutional Animal Care and Use Committee.
Results and discussion
In order to evaluate the staining properties of CDy1 in a format
compatible with high-throughput screening, we transduced
MEFs with different combinations of Oct4, Sox2, Klf-4 and
c-Myc and seeded them in 96 or 384-well plates using a 4:1form. A) CDy1-stained early miPSCs (7 dpi) from different
t for unpaired infected cells showed significant differences (***
e images of CDy1-stained OSK-transduced cells at 7 dpi in 384
taining. White arrows indicate CDy1-stained and Hoechst-stained
in 384well-plates and incubatedwith hydroxamic acids. At 7 dpi,
ut fluorescence cell imaging.
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(dpi), we incubated the cells with CDy1 and observed them
with an ImageXpressMICRO system for high-throughput fluores-
cence cell-imaging data acquisition after washing (Fig. 1A). As
shown in Fig. 1A, the average fluorescence intensity in cells
infected with Oct4, Sox2, Klf-4 and c-Myc (OSKM) wasFigure 2 Time-course experiments and evaluation of 1–26 in rep
B) Reprogramming efficiencies (as relative number ofGFP+ colonies/w
with 1–26 (1 μM) or 5′-azaC (600 nM). Values as means±SEM (n=3).
significant differences (* pb0.1, ** pb0.01) compared to untreated sa
1–26 was determined with a fluorescence-based HDAC drug screenin
microscope images of 1–26 treated Oct4-GFP iPSCs: upper) bright field
Arrows point at CDy1-stained cells whose Oct4-GFP signal is not detect
stage (arrow heads).significantly higher than in cells infected with different
combinations of Oct4, Sox2 and Klf-4 (OSK, OS, OK, and KS)
and non-infected cells. OSKM-transduced cells may render a
significant population of non-iPSC colonies (Nakagawa et al.,
2008) so we analyzed the fluorescence cell images and
observed that CDy1 stained cells resembling early iPSC coloniesrogramming mouse fibroblasts. A) Chemical structure of 1–26.
ell at 28 dpi) inOct4-GFPOSK(M)-transduced cells after treatment
Student's t-test for unpaired chemically-treated samples showed
mples. C) The activity of HDAC under increasing concentrations of
g kit. Values as means±SEM (n=3). D) Time-course fluorescence
, center) Oct4-GFP signal, lower) CDy1 signal (scale bar: 100 μm).
able at the same time point (dashed circles) but appears at a later
Figure 3 Characterization of iPSCs. A) Immunocytochemistry of
SSEA-1 and Oct4 in Oct4-GFP+ colonies: left) Oct4-GFP signal,
center) SSEA-1 or Oct4 immunostainings, right) merged fluores-
cent and bright field images (scale bar: 20 μm). B) RT-PCR analysis
of MEFs, two different 1–26-treated iPSC lines and mESCs. Values
as means±SEM (n=2) of two independent experiments.
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These results confirmed that CDy1 could be efficiently used as
a fluorescent reporter to discriminate early stages of
reprogramming in a high-throughput screening format.
The evaluation of small molecules that can substitute
exogenous transcription factors in iPSC generation is focused
on the replacement of c-Myc, as its oncogenic role hampers
the potential therapeutic application of iPSCs (Huangfu et
al., 2008; Shi et al., 2008a, 2008b). Since CDy1 proved to
discriminate well the reprogramming states of OSK and
OSKM-infected cells at 7 dpi (Fig. 1A), we designed a
CDy1-based screening to identify small molecules that
could replace c-Myc in reprogramming (Okita et al., 2007)
(Fig. 1C). OSK-transduced cells were seeded at 4000 cells/
well into 384-well plates with mitomycin-treated MEF as
feeder cells (1000 cells/well) and incubated in mouse ESC
(mESC) media containing leukemia inhibitory factor (LIF,
100 U/mL) in the presence of a collection of newly
synthesized hydroxamic acids at a final concentration of
5 μM (0.5% DMSO). After 5 days of incubation with the
hydroxamic acids (i.e. 7 dpi), cells were treated with CDy1,
washed with mESC media and analyzed by high-throughput
fluorescence cell-imaging. OSK-transduced cells treated
with 0.5% DMSO and OSKM-transduced cells were included
as controls for non- and full-replacement of c-Myc respec-
tively. Upon evaluation of 240 hydroxamic acids, we
identified 5 compounds inducing higher fluorescence inten-
sities in OSK-infected cells than DMSO and with comparable
responses to various reported chemicals enhancing
reprogramming (e.g. epigenetic modulators: 5′-azacytidine
(5′-azaC) and trichostatin A (TSA) as well as TGFβ inhibitors:
SB431542) (Figure S1 in Supporting Information (SI)).
Secondary screenings showed that 1–26 yielded the largest
population of CDy1-stained cells in a reproducible manner
and suggested that it could partially replace c-Myc to a
similar extent than reported epigenetic modulators, such as
5′-azaC (Huangfu et al., 2008) (Figure S2 in SI).
After identifying 1–26 from the CDy1-based primary
screening, we aimed to confirm the effect of 1–26 (Fig. 2A)
in the reprogramming efficacy using an alternative reported
method. The Oct4-GFP transgene has been extensively used
to monitor the generation of miPSCs, so we examined
OSK-transduced cells harboring an Oct4-GFP reporter upon
continuous incubation with 1–26. The treatment of
Oct4-GFP OSK-transduced cells with 1–26 or 5′-azaC
enhanced the formation of GFP+ colonies at an earlier time
point than DMSO-treated cells with an overall 2.5-fold
increase in the reprogramming efficiency (Fig. 2B). Further-
more, we investigated the biological activity of 1–26 that
may be responsible for this effect. Some hydroxamic acids
(e.g. TSA, suberoylanilide hydroxamic acid) have been reported
as HDAC inhibitors (Finnin et al., 1999; Biel et al., 2005), which
can improve the generation of iPSC reprogramming by inducing
chromatin modifications (Huangfu et al., 2008). 1–26 behaved
as a HDAC inhibitor at micromolar concentrations (Fig. 2C),
which correlated well with its reprogramming effect in
OSK-transduced cells.
In addition, we performed time-course experiments to
compare the fluorescent signal of CDy1 and the conventional
Oct4-GFP reporter on transduced cells treated with 1–26 and
harboring an Oct4-GFP reporter. We treated the cells with
CDy1 at 7 dpi, and monitored both fluorescent signals (i.e.Oct4-GFP and CDy1) at different time points (i.e. 7, 12, 14, 18
and 24 dpi) (Fig. 2D). Cells undergoing reprogramming at early
stages were stained by CDy1 when the signal of Oct4-GFP was
not distinguishable, and consistently overlapped with the
fluorescence of Oct4-GFP at later stages. These experiments
confirmed that CDy1 is an earlier reporter of cells undergoing
reprogramming than theOct4-GFP transgene (Im et al., 2010),
and that the chemical treatment with 1–26 did not affect the
properties of CDy1. With these results we corroborated that
1–26 increases the generation of miPSCs by inhibiting HDACs,
and proved the reliability of our CDy1-based primary screening
to identify small molecules that accelerate the reprogramming
process.
To analyze whether the chemical treatment may affect
the pluripotency of miPSCs, we established miPSC lines from
1–26-treated OSK-infected cells harboring an Oct4-GFP
reporter without further chemical addition. As shown in
Fig. 3, the immunochemical analysis of 1–26-treated miPSCs
showed that GFP+ colonies did also express specific mouse
embryonic stem cell markers, such as SSEA-1 and Oct4
(Fig. 3A). qRT-PCR analysis of two different miPSC lines
indicated that the endogenous levels of Nanog, Oct4, Sox2,
Klf4 and c-Myc in 1–26-treated miPSCs were higher than in
MEFs and similar to those expressed in mESC (Fig. 3B).
Figure 4 Differentiation of iPSCs. A) Immunocytochemistry of in vitro differentiated cells with anti-α-SMA (mesoderm), anti-Nestin
(ectoderm) and anti-SOX17 (endoderm) (scale bar: 20 μm). Hoechst was used for nuclear counterstaining. B) In vivo teratoma assay.
Staining with hematoxylin and eosin of three germ layers (endoderm, mesoderm, and ectoderm) differentiated from 1–26-treated
iPSCs: a) goblet cells of the endodermal germ layer originated intestine epithelia (arrow heads), b and c) mesodermal smooth muscle
cells (b) and cartilages (c), d) neuronal rosettes of ectodermal origin (arrows) (scale bar: 100 μm).
190 M. Vendrell et al.Furthermore, these cells were induced to form embryoid
bodies and further differentiated under culturing conditions
without LIF into a mixed population of cells including the three
embryonic germ layers (e.g. mesoderm, ectoderm and endo-
derm) as confirmed by immunochemical analysis (e.g.α-smooth
muscle actin (α-SMA), Nestin and Sox 17 respectively) (Fig. 4A).
Lastly, we demonstrated the capability of 1–26-treatedmiPSCs
to differentiate into all three germ layers by means of teratoma
assays (Fig. 4B), which illustrates the pluripotent nature of the
generated lines.Conclusions
We developed a high-throughput screening platform to
evaluate small molecules enhancing the generation of miPSCs
using the fluorescent signal of CDy1 as an earlier reporter (i.e.
7 dpi) than previously describedmethods. In a proof of concept
application, we examined a collection of synthesized
hydroxamic acids in OSK-transduced cells and identified 1–26
as a small molecule capable to induce a large population of
CDy1-stained cells. Further experiments indicated that 1–26
behaved as a HDAC inhibitor and confirmed a 2.5-fold increase
in the reprogramming efficiency of Oct4-GFP OSK-transducedcells. The versatility, speed and simplicity of this CDy1-based
high-throughput screening make it a suitable platform for the
rapid evaluation of iPSC reprogramming modulators.Acknowledgments
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